Literature DB >> 19050970

Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes.

Da-zhi Xu1, Qi-rong Geng, Zi-jie Long, You-qing Zhan, Wei Li, Zhi-wei Zhou, Ying-bo Chen, Xiao-wei Sun, Gong Chen, Quentin Liu.   

Abstract

The purpose of this study was to clarify the outcome of the ratio between metastatic and examined lymph nodes (N ratio) in gastric cancer patients with < or =15 examined lymph nodes after D2 lymphadenectomy. A retrospective study was performed in 906 patients with gastric cancer who had undergone D2 resection. Patients with < or =15 examined lymph nodes (group 1, n = 729) and those with >15 lymph nodes (group 2, n = 177) were analyzed separately. N ratio categories were identified as follows: N ratio 0, 0%; N ratio 1, 1% to 9%; N ratio 2, 10% to 25%; N ratio 3, >25%. Univariate analysis found that both the tumor, node, metastasis system (N staging system) and N ratio system well classified patients with significantly different prognosis. By multivariate analysis, only the N ratio classification was retained as an independent prognostic factor in both group 1 and 2 compared with the N stage system. Furthermore, when patients were divided into four groups according to the number of lymph nodes examined (1 to 3, 4 to 7, 8 to 11, and 12 to 15), the 5-year survival rates remained similar between groups according to the same N ratio (p > .05). Positive N ratio classification is a better prognostic tool compared with N staging system after D2 resection in patients with gastric cancer. It can prevent stage migration and can be used regardless of the examined number of lymph nodes.

Entities:  

Mesh:

Year:  2008        PMID: 19050970     DOI: 10.1245/s10434-008-0240-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  47 in total

1.  Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer.

Authors:  Long-Bin Xiao; Jian-Xing Yu; Wen-Hui Wu; Feng-Feng Xu; Shi-Bin Yang
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

2.  Lymph node retrieval and examination during the implementation of extended lymph node dissection for gastric cancer in a non-specialized western institution.

Authors:  Marco Catarci; Leonardo Antonio Montemurro; Antonio Di Cintio; Sabrina Ghinassi; Luigi Coppola; Luigi Pinnarelli; Augusto Belardi; Maurizio Koch; Giovanni Battista Grassi
Journal:  Updates Surg       Date:  2010-10

3.  How does epidemiological and clinicopathological features affect survival after gastrectomy for gastric cancer patients-single Egyptian center experience.

Authors:  Ehab El Hanafy; Ayman El Nakeeb; Helmy Ezzat; Emad Hamdy; Ehab Atif; Tharwat Kandil; Amgad Fouad; Mohamed Abdel Wahab; Ahmed Monier
Journal:  World J Gastrointest Surg       Date:  2016-06-27

4.  Correlation between metastatic lymph node ratio and prognosis in patients with extrahepatic cholangiocarcinoma.

Authors:  Jian-Wei Zhang; Yun-Mian Chu; Zhong-Min Lan; Xiao-Long Tang; Ying-Tai Chen; Cheng-Feng Wang; Xu Che
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

5.  Log odds of positive lymph nodes (LODDS): what are their role in the prognostic assessment of gastric adenocarcinoma?

Authors:  Paolo Aurello; Niccolò Petrucciani; Giuseppe R Nigri; Marco La Torre; Paolo Magistri; Simone Tierno; Francesco D'Angelo; Giovanni Ramacciato
Journal:  J Gastrointest Surg       Date:  2014-05-20       Impact factor: 3.452

6.  Is it worthy of adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for distal gastric cancers with No. 6 lymph node metastasis?

Authors:  J Zhang; S Zou; R Luo; Z Zhu; Z Wang; H Xu; B Huang
Journal:  Clin Transl Oncol       Date:  2019-04-11       Impact factor: 3.405

7.  Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer.

Authors:  Kazuki Kano; Takanobu Yamada; Kouji Yamamoto; Keisuke Komori; Hayato Watanabe; Kentaro Hara; Yota Shimoda; Yukio Maezawa; Hirohito Fujikawa; Toru Aoyama; Hiroshi Tamagawa; Naoto Yamamoto; Haruhiko Cho; Manabu Shiozawa; Norio Yukawa; Takaki Yoshikawa; Soichiro Morinaga; Yasushi Rino; Munetaka Masuda; Takashi Ogata; Takashi Oshima
Journal:  Ann Surg Oncol       Date:  2020-05-18       Impact factor: 5.344

8.  Relationship between H.Pylori infection and clinicopathological features and prognosis of gastric cancer.

Authors:  Hai-Bo Qiu; Li-Yi Zhang; Rajiv-Prasad Keshari; Guo-Qiang Wang; Zhi-Wei Zhou; Da-Zhi Xu; Wei Wang; You-Qin Zhan; Wei Li
Journal:  BMC Cancer       Date:  2010-07-17       Impact factor: 4.430

9.  Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer.

Authors:  Da-zhi Xu; Qi-rong Geng; Ying Tian; Mu-yan Cai; Xin-juan Fang; You-qing Zhan; Zhi-wei Zhou; Wei Li; Ying-bo Chen; Xiao-wei Sun; Yuan-xiang Guan; Yuan-fang Li; Tong-yu Lin
Journal:  BMC Cancer       Date:  2010-10-07       Impact factor: 4.430

10.  Gastric cancer: predictors of recurrence when lymph-node dissection is inadequate.

Authors:  Esther Uña
Journal:  World J Surg Oncol       Date:  2009-09-17       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.